Skip to main content
Funded Studies

Ethan Burstein, PhD

Director of Biosciences at Acadia Pharmaceuticals

Location: San Diego, CA United States

Ethan Burstein is Director of Biosciences at ACADIA, where he leads drug discovery pharmacology. Dr. Burstein has published approximately 60 peer-reviewed papers on the molecular pharmacology of receptors and discovery of small molecule receptor ligands and is one of the inventors of ACADIA‰Ûªs R-SATå¨ high-throughput screening technology. Prior to ACADIA, Dr. Burstein was a research fellow at the University of Vermont where he received a National Research Service Award Fellowship to study the biochemistry of receptor signaling. Dr. Burstein received his PhD in Toxicology at the University of Rochester.

Associated Grants

  • Development of Nurr1-RXR Heterodimer Selective Agonists for Parkinson's Disease

    2012


  • Development of Nurr1-RXR Heterodimer Selective Agonists for Parkinson's Disease

    2012


  • Development of Nurr1-RXR heterodimer selective agonists for Parkinson's disease

    2010


  • Identification of Nurr1 Agonists for the Treatment of Parkinson's Disease

    2009


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.